Seek Returns

IQV vs. TECH: IQVIA vs. Bio-Techne Stock Comparison

How do IQVIA (IQV) and Bio-Techne (TECH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

IQVIA (IQV) and Bio-Techne (TECH) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for IQVIA (IQV) and Bio-Techne (TECH)
Profile ItemIQVTECH
NameIQVIA Holdings Inc.Bio-Techne Corp.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization44.80 billion USD11.43 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateMay 9, 2013February 9, 1989
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

IQV
TECH
GSPC
Loading price history…
IQVIA (IQV) vs. Bio-Techne (TECH), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for IQVIA (IQV) and Bio-Techne (TECH). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for IQVIA (IQV) and Bio-Techne (TECH). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
Total Return (1Y)32.11%27.56%
Total Return (3Y, Annualized)13.15%9.11%
Total Return (5Y, Annualized)2.00%-9.91%

Risk Profile

Drawdown History

IQV
TECH
GSPC
Loading price history…
IQVIA (IQV) vs. Bio-Techne (TECH), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for IQVIA (IQV) and Bio-Techne (TECH). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
Volatility (1Y, Annualized)40.77%43.08%
Beta (5Y)1.141.26
Max Drawdown (5Y)-51.52%-65.87%
Avg. Volume (3M)1.40M2.81M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
IQV and TECH are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
Sharpe Ratio (1Y)0.680.54
Sortino Ratio (1Y)1.030.82

Profitability

ROE (TTM)

Both IQVIA (IQV) at 21.39% and Bio-Techne (TECH) at 8.33% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.39%

Max
109.18%
IQV
21.39%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.33%

Max
109.18%
TECH
8.33%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both IQVIA (IQV) at 8.05% and Bio-Techne (TECH) at 14.00% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.05%

Max
18.05%
IQV
8.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

14.00%

Max
18.05%
TECH
14.00%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both IQVIA (IQV) at 13.73% and Bio-Techne (TECH) at 12.21% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.73%

Max
83.12%
Q3
14.77%
IQV
13.73%
Median
0.00%
Q1
-78.82%
Min
-207.40%

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

12.21%

Max
83.12%
Q3
14.77%
TECH
12.21%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
ROE (TTM)21.39%8.33%
ROA (TTM)5.08%6.38%
Net Margin (TTM)8.05%14.00%
Operating Margin (TTM)13.73%12.21%
Gross Margin (TTM)33.07%66.23%

Growth

Revenue Growth

Both IQVIA (IQV) at 5.87% and Bio-Techne (TECH) at -0.38% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their Revenue Growth across different time periods.

EPS Growth

Bio-Techne (TECH) at 152.17% sits in the top EPS growth quartile, while IQVIA (IQV) at 4.67% is closer to the peer norm — faster per-share earnings growth for TECH.

Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
Revenue Growth (YoY)5.87%-0.38%
Revenue Growth (3Y CAGR)4.21%2.25%
EPS Growth (YoY)4.67%152.17%
EPS Growth (3Y CAGR)11.08%-12.97%

Financial Strength

Current Ratio (MRQ)

Both IQVIA (IQV) at 0.83 and Bio-Techne (TECH) at 2.28 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.83

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
IQV
0.83
Min
0.10

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.28

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
TECH
2.28
Min
0.10
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Bio-Techne (TECH) at 0.13 is near its industry mid-range for debt-to-equity ratio, while IQVIA (IQV) at 2.40 sits above its benchmark range, pointing to a heavier debt load relative to equity.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40

IQV
2.40
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.13

Max
1.42
Q3
0.65
Median
0.15
TECH
0.13
Q1
0.02
Min
0.00
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
Current Ratio (MRQ)0.832.28
Debt / Equity (MRQ)2.400.13
Net Debt / EBITDA4.46-0.20

Dividends

Dividend Yield (TTM)

IQVIA (IQV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Bio-Techne (TECH) reports a yield of 0.44%, ranking against industry peers normally.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.44%

TECH
0.44%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

IQVIA (IQV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Bio-Techne (TECH) reports a payout of 27.59%, ranking against industry peers normally.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.59%

TECH
27.59%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
Dividend Yield (TTM)0.00%0.44%
Dividend Payout Ratio (TTM)0.00%27.59%

Valuation

P/E Ratio (TTM)

IQVIA (IQV) at 33.07 is near its industry’s usual P/E ratio, while Bio-Techne (TECH) at 62.74 sits in the richer quartile — TECH needs stronger growth or earnings quality to justify the premium.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.07

Max
85.34
Q3
43.46
IQV
33.07
Median
26.69
Q1
13.30
Min
0.07

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

62.74

Max
85.34
TECH
62.74
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

IQVIA (IQV) at 2.59 sits in the cheaper P/S ratio quartile while Bio-Techne (TECH) at 9.31 prices around its industry’s middle — IQV costs less per dollar of sales, though read it alongside growth and margins.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.59

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
IQV
2.59
Min
0.01

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.31

Max
58.18
Q3
25.77
TECH
9.31
Median
7.30
Q1
3.01
Min
0.01
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Bio-Techne (TECH) at 5.28 is valued about in line with its industry on P/B ratio, while IQVIA (IQV) at 6.73 carries an above-peer premium to book — IQV is pricier on assets.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.73

Max
13.53
IQV
6.73
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

TECH

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.28

Max
13.53
Q3
6.54
TECH
5.28
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
IQVIA (IQV) vs. Bio-Techne (TECH): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for IQVIA (IQV) and Bio-Techne (TECH)
MetricIQVTECH
P/E Ratio (TTM)33.0762.74
P/S Ratio (TTM)2.599.31
P/B Ratio (MRQ)6.735.28
Free Cash Flow Yield (TTM)4.72%2.39%